Liquid Biopsies and Minimally-Invasive Diagnostics 2016
In-Person Event
Sep 29 - 30, 2016
San Diego, California, USASpeakers
OVERVIEW
Liquid Biopsies and Minimally-Invasive Diagnostics 2016, is organized by SELECTBIO Ltd and would be held during Sep 29 - 30, 2016 at San Diego Marriott Mission Valley, San Diego, California, United States of America.
The targeted audience for this medical event basically for academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.
The Liquid Biopsies Conference Track focuses primarily on biofluid based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state of the field.
The Minimally-Invasive Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.
The targeted audience for this medical event basically for academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.
The Liquid Biopsies Conference Track focuses primarily on biofluid based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state of the field.
The Minimally-Invasive Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.
KEY DATES
29 Sep, 2016
Event Start Date
30 Sep, 2016
Event End Date
SPECIALITIES
Biochemistry and Molecular GeneticsResearch and Clinical ResearchSUGGESTED HOTELS
CONFERENCE VENUE
San Diego Marriott Mission ValleyRELATED CONFERENCES & LIVE WEBINARS
Quick Links